Christopher Rowan


Founder & Managing Partner, Arscientia

Chris is the founder of Arscientia and has 30 years of executive management experience as a GM, in marketing, sales, and business development. He has experience in the semiconductor, software, FinTech, chemical, advanced materials, and photonics industries. His key strengths include strategic planning, new business development, process invention, forecasting, and new product introductions. Chris is the inventor of the Consistency of Purpose (CoP) and Risk to Value (R2V) strategic planning processes. He has successfully launched 5 new product lines. As a GM and responsible for strategic marketing at Cymer, sales increased from $6 million to $203 million in less than 3 years with a market share over 90% and two years later to approximately $0.5 billion. Chris was a SEMATECH ITRS roadmap voting member, obtained a $1.1 SEMATECH contract for optical material testing, won a DOE CRADA for superconductor research and analysis. Chris holds two software patents and has served on 3 boards and 5 advisory boards: a founding board member of the Design Museum of Boston, Strategic Advisor to NewCap Partners, an MIT Enterprise Forum Co-Programing Chair, a mentor at UCSD’s NSF I-corps program, moderator an IEEE panel on IoT, MIT forum on AI in health care, a BlueTech judge, Prism Award judge in 2018 & 2019. He is currently a Cove Fund partner, a patent pending in decision making software. He earned a BS in Chemical Engineering from the University of Connecticut and was awarded the Hurley Calculus Award.

Your area of FinTech expertise:

Fund of Funds, Hedge funds, risk management, VC, Investment Banking, Decision Making Tools

Your area of technical expertise:

AI, machine learning, insurance tech, predictive behavior analytics, back office & operations software, marketing, two-sided markets, investment committee